Zhejiang Hisun Pharmaceutical Co Ltd

600267

Company Profile

  • Business description

    Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.

  • Contact

    No. 46 Waisha Road
    Jiaojiang District
    Zhejiang Province
    Taizhou318000
    CHN

    T: +86 4001180618

    http://www.hisunpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    7,994

Stocks News & Analysis

stocks

This might be the best core stock bargain in the US market today

Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.
stocks

Data center demand drives strong earnings outlook for SGM

Sims guides huge earnings upgrade as data center metals demand spikes.
stocks

Chart of the Week: AI proving a threat to company moats

The latest insights on AI from our equity research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,628.3034.80-0.40%
CAC 407,806.761.11-0.01%
DAX 4022,817.7221.84-0.10%
Dow JONES (US)46,046.8325.400.06%
FTSE 10010,082.4418.940.19%
HKSE25,277.32223.26-0.88%
NASDAQ21,973.90116.79-0.53%
Nikkei 22553,372.531,866.87-3.38%
NZX 50 Index12,989.9961.62-0.47%
S&P 5006,591.5014.99-0.23%
S&P/ASX 2008,428.4043.90-0.52%
SSE Composite Index3,957.0549.50-1.24%

Market Movers